Arash Mirabzadeh
Full Professor, Department of Social Determinants of Health Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.| Full Professor, Department of Psychiatry, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
[ 1 ] - A Path Analysis of the Effects of Mental Health and Socio-personal Factors on Breastfeeding Problems in Infants Aged Less than Six Months
Background: Despite the large number of studies conducted on breastfeeding, no studies have yet examined the direct and indirect effects of socio-personal factors and mental health on breastfeeding. Aim: This study aimed to analyze of the effects of mental health and socio-personal factors on breastfeeding in infants aged less than six months. Method: This analytical cross-sectional study was c...
[ 2 ] - Assessment of Lippia Citriodora Oil Effect on Sleep Disturbances in Ageing: A Double Blind Randomized Controlled Trial
Objectives: The elderly population is increasing globally and as the age increases and the functions of some organs decrease, some problems in elderly age, including sleep problems increase. Sleep disturbances cause neurological, autonomic, and biological changes. Therefore, attention should be paid to the problems that eliciting for the elderly and their families subsequently. The aim of this ...
[ 3 ] - Physical Rehabilitation Accessibility Assessment Questionnaire for People With Physical Disability: A Development and Validation Study in Iran
Objectives: The primary focus in the rehabilitation services program is the universal coverage of these services, in other words, to provide better access to these services in any place and situation. The present study aimed to develop and validate a physical rehabilitation accessibility assessment questionnaire as a standardized instrument that can be adaptable to people with physical disabili...
[ 4 ] - Investigation of DRD2 and HTR2A mRNA Expression in Two Therapeutic States of Antipsychotic Polypharmacy and Aripiprazole Monotherapy in the Peripheral Blood of Patients With Schizophrenia
Objectives: Schizophrenia is a severe psychiatric disorder that has profound effects on both individuals and the community. Notwithstanding the suggestion for treating schizophrenia with a minimum dose of drugs, antipsychotic polypharmacy increases the patient’s care costs and drug interactions. Aripiprazole reduces the metabolic side effects of antipsychotic polypharmacy treatment. DRD2 and HT...
Co-Authors